CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer

被引:49
作者
Coventry, BJ
Morton, J
机构
[1] Univ Adelaide, Royal Adelaide Hosp, Dept Surg, Breast Endocrine & Surg Oncol Unit, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Royal Adelaide Hosp, Dept Surg, Tumour Immunol Lab, Adelaide, SA 5000, Australia
关键词
CD1a; dendritic cells; breast cancer; survival;
D O I
10.1038/sj.bjc.6601114
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Infiltrating CD1a(+) dendritic cells (DCs) have been associated with increased survival in a number of human cancers. This study investigated DC infiltration within breast cancers and the association with survival. Classical established prognostic factors, of tumour size, lymph node status, histological grade, lympho-vascular invasion, the KI-67 (MIB-1) fraction and the Nottingham Prognostic Index (NPI) were also compared. A total of 48 breast cancer patients were followed from the time of surgery and CD1a density analysis for 5 years or until death. Our data set validated previous studies, which show a relationship between survival and the NPI (P<0.001), tumour size (P<0.01) and lymph node status (P<0.05). Although more patients were alive at the 5-year time point in the group with higher CD1a DC density than the lower CD1a DC group, this failed to reach statistical significance at the P = 0.05 level. Analysis at 10 years postsurgery is required to investigate the association further.
引用
收藏
页码:533 / 538
页数:6
相关论文
共 71 条
  • [41] MONOCLONAL-ANTIBODY TO CYTOKERATIN FOR USE IN ROUTINE HISTOPATHOLOGY
    MAKIN, CA
    BOBROW, LG
    BODMER, WF
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1984, 37 (09) : 975 - 983
  • [42] MATSUDA H, 1990, CANCER, V65, P2261, DOI 10.1002/1097-0142(19900515)65:10<2261::AID-CNCR2820651017>3.0.CO
  • [43] 2-8
  • [44] Nixon AJ, 1996, CANCER, V78, P1426, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1426::AID-CNCR8>3.0.CO
  • [45] 2-I
  • [46] NOMORI H, 1986, CANCER, V57, P100, DOI 10.1002/1097-0142(19860101)57:1<100::AID-CNCR2820570121>3.0.CO
  • [47] 2-X
  • [48] Routinely available indicators of prognosis in breast cancer
    Page, DL
    Jensen, RA
    Simpson, JF
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 51 (03) : 195 - 208
  • [49] PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .4. SHOULD YOU BE A TYPER OR A GRADER - A COMPARATIVE-STUDY OF 2 HISTOLOGICAL PROGNOSTIC FEATURES IN OPERABLE BREAST-CARCINOMA
    PEREIRA, H
    PINDER, SE
    SIBBERING, DM
    GALEA, MH
    ELSTON, CW
    BLAMEY, RW
    ROBERTSON, JFR
    ELLIS, IO
    [J]. HISTOPATHOLOGY, 1995, 27 (03) : 219 - 226
  • [50] ASSESSMENT OF THE NEW PROLIFERATION MARKER MIB1 IN BREAST-CARCINOMA USING IMAGE-ANALYSIS - ASSOCIATIONS WITH OTHER PROGNOSTIC FACTORS AND SURVIVAL
    PINDER, SE
    WENCYK, P
    SIBBERING, DM
    BELL, JA
    ELSTON, CW
    NICHOLSON, R
    ROBERTSON, JFR
    BLAMEY, RW
    ELLIS, IO
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (01) : 146 - 149